Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group Study AREN0532

BACKGROUND: The National Wilms Tumor Study (NWTS) approach to treating stage III favorable-histology Wilms tumor (FHWT) is Regimen DD4A (vincristine, dactinomycin, and doxorubicin) and radiation therapy. Further risk stratification is required to improve outcomes and reduce late effects. We evaluate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Fernandez, Conrad V., Mullen, Elizabeth A., Chi, Yueh-Yun, Ehrlich, Peter F., Perlman, Elizabeth J., Kalapurakal, John A., Khanna, Geetika, Paulino, Arnold C., Hamilton, Thomas E., Gow, Kenneth W., Tochner, Zelig, Hoffer, Fredric A., Withycombe, Janice S., Shamberger, Robert C., Kim, Yeonil, Geller, James I., Anderson, James R., Grundy, Paul E., Dome, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773840/
https://ncbi.nlm.nih.gov/pubmed/29211618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.7999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados